


{"id":43505,"date":"2021-06-02T11:15:55","date_gmt":"2021-06-02T09:15:55","guid":{"rendered":"https:\/\/newserver.fyb.de\/leaps-by-bayer-leads-usd-90m-series-b-round-in-ada-health\/"},"modified":"2021-06-02T11:15:55","modified_gmt":"2021-06-02T09:15:55","slug":"leaps-by-bayer-leads-usd-90m-series-b-round-in-ada-health","status":"publish","type":"post","link":"https:\/\/www.fyb.de\/en\/leaps-by-bayer-leads-usd-90m-series-b-round-in-ada-health\/","title":{"rendered":"Leaps by Bayer leads USD 90m Series B round in Ada Health"},"content":{"rendered":"<p>Berlin \u2014 Leaps by Bayer is inves\u00adt\u00ading in Berlin-based digi\u00adtal health company Ada Health as part of its Series B finan\u00adcing round. The finan\u00adcing round is worth $90 million and was led by Leaps by Bayer. In addi\u00adtion, inves\u00adtors Samsung Cata\u00adlyst Fund, Vitru\u00advian Part\u00adners, Inteligo Bank, F4 and Mutsch\u00adler Ventures parti\u00adci\u00adpa\u00adted in the round. SMP provi\u00added compre\u00adhen\u00adsive legal advice to Leaps by Bayer on the Series B finan\u00adcing round of Berlin-based digi\u00adtal health company Ada Health.<\/p>\n<p>Leaps by Bayer is the impact invest\u00adment unit of the phar\u00admaceu\u00adti\u00adcal company Bayer AG, which uses its invest\u00adments to find solu\u00adti\u00adons to some of the biggest chal\u00adlenges of our time in the fields of health and agri\u00adcul\u00adture. The invest\u00adment in Ada Health is Leaps\u2019 first commit\u00adment in Germany.<\/p>\n<p>Ada has deve\u00adlo\u00adped a powerful arti\u00adfi\u00adcial intel\u00adli\u00adgence (AI)-based health analy\u00adtics plat\u00adform. It is desi\u00adgned to help users better under\u00adstand their symptoms and iden\u00adtify and diffe\u00adren\u00adtiate dise\u00adase patterns with great medi\u00adcal accu\u00adracy. At the same time, the plat\u00adform supports users in finding the right medi\u00adcal care in a timely and safe manner. The Ada app, which is aimed at consu\u00admers, has alre\u00adady recor\u00added more than 23 million health analy\u00adses perfor\u00admed world\u00adwide since its global launch. The goal of the funding, accor\u00adding to the company, is to further advance Ada\u2019s tech\u00adno\u00adlo\u00adgies and acce\u00adle\u00adrate the company\u2019s path to beco\u00adming the global leader in perso\u00adna\u00adli\u00adzed digi\u00adtal health. This is also inten\u00added to streng\u00adthen the company\u2019s leading posi\u00adtion in the&nbsp;USA.<\/p>\n<p>\u201cWe are very plea\u00adsed to have supported the Leaps team in this invest\u00adment in a German company that aims to improve global access to health\u00adcare through digi\u00adta\u00adliza\u00adtion,\u201d said Stephan Bank.<\/p>\n<p><strong>Consul\u00adtant Leaps by Bayer: SMP<\/strong><br>\nDr. Stephan Bank (Lead), Partner<br>\nDr. Florian Wilbrink, Associate<br>\nDr. Chris\u00adtoph L\u00fctten\u00adberg, Associate<br>\nPeter Sch\u00e4\u00adfer, Associate<\/p>\n<p><strong>About SMP<\/strong><br>\nSMP is a specia\u00adlist tax and commer\u00adcial law firm opera\u00adting in the core areas of corpo\u00adrate, funds, liti\u00adga\u00adtion, tax and tran\u00adsac\u00adtions. SMP\u2019s attor\u00adneys and tax advi\u00adsors repre\u00adsent a wide variety of clients. These include emer\u00adging tech\u00adno\u00adlogy compa\u00adnies and family-run medium-sized enter\u00adpri\u00adses as well as corpo\u00adra\u00adti\u00adons and private equity\/venture capi\u00adtal funds. Since its foun\u00adda\u00adtion in 2017, SMP has become one of the leading addres\u00adses for venture capi\u00adtal, private equity and fund struc\u00adtu\u00adring in Germany. The firm and its part\u00adners are natio\u00adnally and inter\u00adna\u00adtio\u00adnally ranked by JUVE, Best Lawy\u00aders, Legal 500, Focus, and Cham\u00adbers and Part\u00adners. Today, SMP employs more than 70 expe\u00adri\u00aden\u00adced lawy\u00aders, tax advi\u00adsors and tax specia\u00adlists in three offices in Berlin, Hamburg and Colo\u00adgne. For more infor\u00adma\u00adtion: www.smp.law and www.linkedin.com\/company\/smp.law.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Berlin \u2014 Leaps by Bayer is inves\u00adt\u00ading in Berlin-based digi\u00adtal health company Ada Health as part of its Series B finan\u00adcing round. The finan\u00adcing round is worth $90 million and was led by Leaps by Bayer. In addi\u00adtion, inves\u00adtors Samsung Cata\u00adlyst Fund, Vitru\u00advian Part\u00adners, Inteligo Bank, F4 and Mutsch\u00adler Ventures parti\u00adci\u00adpa\u00adted in the round. SMP&nbsp;[\u2026]<\/p>\n","protected":false},"author":2,"featured_media":37497,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"wp_typography_post_enhancements_disabled":false,"footnotes":""},"categories":[886,1364,1366,1367,1369,1373],"tags":[],"class_list":["post-43505","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-general-en","category-featured-en","category-news-en","category-lawyers-tax-advisors-auditors-en","category-investors","category-venture-capital-en"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v25.1 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Leaps by Bayer leads USD 90m Series B round in Ada Health - FYB Financial Yearbook<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.fyb.de\/en\/leaps-by-bayer-leads-usd-90m-series-b-round-in-ada-health\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Leaps by Bayer leads USD 90m Series B round in Ada Health - FYB Financial Yearbook\" \/>\n<meta property=\"og:description\" content=\"Berlin \u2014 Leaps by Bayer is inves\u00adt\u00ading in Berlin-based digi\u00adtal health company Ada Health as part of its Series B finan\u00adcing round. The finan\u00adcing round is worth $90 million and was led by Leaps by Bayer. In addi\u00adtion, inves\u00adtors Samsung Cata\u00adlyst Fund, Vitru\u00advian Part\u00adners, Inteligo Bank, F4 and Mutsch\u00adler Ventures parti\u00adci\u00adpa\u00adted in the round. SMP [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.fyb.de\/en\/leaps-by-bayer-leads-usd-90m-series-b-round-in-ada-health\/\" \/>\n<meta property=\"og:site_name\" content=\"FYB Financial Yearbook\" \/>\n<meta property=\"article:published_time\" content=\"2021-06-02T09:15:55+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.fyb.de\/wp-content\/uploads\/2021\/06\/leaps-by-bayer.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"848\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Tatjana Anderer\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Tatjana Anderer\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.fyb.de\/en\/leaps-by-bayer-leads-usd-90m-series-b-round-in-ada-health\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.fyb.de\/en\/leaps-by-bayer-leads-usd-90m-series-b-round-in-ada-health\/\"},\"author\":{\"name\":\"Tatjana Anderer\",\"@id\":\"https:\/\/www.fyb.de\/en\/#\/schema\/person\/4308b3086925bc8567ceba3ebd69b4ce\"},\"headline\":\"Leaps by Bayer leads USD 90m Series B round in Ada Health\",\"datePublished\":\"2021-06-02T09:15:55+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.fyb.de\/en\/leaps-by-bayer-leads-usd-90m-series-b-round-in-ada-health\/\"},\"wordCount\":436,\"publisher\":{\"@id\":\"https:\/\/www.fyb.de\/en\/#organization\"},\"image\":{\"@id\":\"https:\/\/www.fyb.de\/en\/leaps-by-bayer-leads-usd-90m-series-b-round-in-ada-health\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.fyb.de\/wp-content\/uploads\/2021\/06\/leaps-by-bayer.jpg\",\"articleSection\":[\"General\",\"Featured\",\"News\",\"Lawyers\/Tax-advisors\/Auditors\",\"Investors\",\"Venture Capital\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.fyb.de\/en\/leaps-by-bayer-leads-usd-90m-series-b-round-in-ada-health\/\",\"url\":\"https:\/\/www.fyb.de\/en\/leaps-by-bayer-leads-usd-90m-series-b-round-in-ada-health\/\",\"name\":\"Leaps by Bayer leads USD 90m Series B round in Ada Health - FYB Financial Yearbook\",\"isPartOf\":{\"@id\":\"https:\/\/www.fyb.de\/en\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.fyb.de\/en\/leaps-by-bayer-leads-usd-90m-series-b-round-in-ada-health\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.fyb.de\/en\/leaps-by-bayer-leads-usd-90m-series-b-round-in-ada-health\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.fyb.de\/wp-content\/uploads\/2021\/06\/leaps-by-bayer.jpg\",\"datePublished\":\"2021-06-02T09:15:55+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/www.fyb.de\/en\/leaps-by-bayer-leads-usd-90m-series-b-round-in-ada-health\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.fyb.de\/en\/leaps-by-bayer-leads-usd-90m-series-b-round-in-ada-health\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.fyb.de\/en\/leaps-by-bayer-leads-usd-90m-series-b-round-in-ada-health\/#primaryimage\",\"url\":\"https:\/\/www.fyb.de\/wp-content\/uploads\/2021\/06\/leaps-by-bayer.jpg\",\"contentUrl\":\"https:\/\/www.fyb.de\/wp-content\/uploads\/2021\/06\/leaps-by-bayer.jpg\",\"width\":1200,\"height\":848,\"caption\":\"Leaps by Bayer\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.fyb.de\/en\/leaps-by-bayer-leads-usd-90m-series-b-round-in-ada-health\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.fyb.de\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Leaps by Bayer leads USD 90m Series B round in Ada Health\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.fyb.de\/en\/#website\",\"url\":\"https:\/\/www.fyb.de\/en\/\",\"name\":\"FYB Financial Yearbook\",\"description\":\"For Your Business\",\"publisher\":{\"@id\":\"https:\/\/www.fyb.de\/en\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.fyb.de\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.fyb.de\/en\/#organization\",\"name\":\"FYB Financial Yearbook\",\"url\":\"https:\/\/www.fyb.de\/en\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.fyb.de\/en\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.fyb.de\/wp-content\/uploads\/2020\/06\/logo.svg\",\"contentUrl\":\"https:\/\/www.fyb.de\/wp-content\/uploads\/2020\/06\/logo.svg\",\"caption\":\"FYB Financial Yearbook\"},\"image\":{\"@id\":\"https:\/\/www.fyb.de\/en\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.fyb.de\/en\/#\/schema\/person\/4308b3086925bc8567ceba3ebd69b4ce\",\"name\":\"Tatjana Anderer\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.fyb.de\/en\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/11708a5289b743e6290bae8e4109e97efec1cb1ae5c7065f0bfc5c36f28c7757?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/11708a5289b743e6290bae8e4109e97efec1cb1ae5c7065f0bfc5c36f28c7757?s=96&d=mm&r=g\",\"caption\":\"Tatjana Anderer\"},\"description\":\"Gr\u00fcnderin des FYB-Verlag\",\"sameAs\":[\"http:\/\/neu.fyb.de\"],\"url\":\"https:\/\/www.fyb.de\/en\/author\/tanderer\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Leaps by Bayer leads USD 90m Series B round in Ada Health - FYB Financial Yearbook","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.fyb.de\/en\/leaps-by-bayer-leads-usd-90m-series-b-round-in-ada-health\/","og_locale":"en_US","og_type":"article","og_title":"Leaps by Bayer leads USD 90m Series B round in Ada Health - FYB Financial Yearbook","og_description":"Berlin \u2014 Leaps by Bayer is inves\u00adt\u00ading in Berlin-based digi\u00adtal health company Ada Health as part of its Series B finan\u00adcing round. The finan\u00adcing round is worth $90 million and was led by Leaps by Bayer. In addi\u00adtion, inves\u00adtors Samsung Cata\u00adlyst Fund, Vitru\u00advian Part\u00adners, Inteligo Bank, F4 and Mutsch\u00adler Ventures parti\u00adci\u00adpa\u00adted in the round. SMP [&hellip;]","og_url":"https:\/\/www.fyb.de\/en\/leaps-by-bayer-leads-usd-90m-series-b-round-in-ada-health\/","og_site_name":"FYB Financial Yearbook","article_published_time":"2021-06-02T09:15:55+00:00","og_image":[{"width":1200,"height":848,"url":"https:\/\/www.fyb.de\/wp-content\/uploads\/2021\/06\/leaps-by-bayer.jpg","type":"image\/jpeg"}],"author":"Tatjana Anderer","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Tatjana Anderer","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.fyb.de\/en\/leaps-by-bayer-leads-usd-90m-series-b-round-in-ada-health\/#article","isPartOf":{"@id":"https:\/\/www.fyb.de\/en\/leaps-by-bayer-leads-usd-90m-series-b-round-in-ada-health\/"},"author":{"name":"Tatjana Anderer","@id":"https:\/\/www.fyb.de\/en\/#\/schema\/person\/4308b3086925bc8567ceba3ebd69b4ce"},"headline":"Leaps by Bayer leads USD 90m Series B round in Ada Health","datePublished":"2021-06-02T09:15:55+00:00","mainEntityOfPage":{"@id":"https:\/\/www.fyb.de\/en\/leaps-by-bayer-leads-usd-90m-series-b-round-in-ada-health\/"},"wordCount":436,"publisher":{"@id":"https:\/\/www.fyb.de\/en\/#organization"},"image":{"@id":"https:\/\/www.fyb.de\/en\/leaps-by-bayer-leads-usd-90m-series-b-round-in-ada-health\/#primaryimage"},"thumbnailUrl":"https:\/\/www.fyb.de\/wp-content\/uploads\/2021\/06\/leaps-by-bayer.jpg","articleSection":["General","Featured","News","Lawyers\/Tax-advisors\/Auditors","Investors","Venture Capital"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.fyb.de\/en\/leaps-by-bayer-leads-usd-90m-series-b-round-in-ada-health\/","url":"https:\/\/www.fyb.de\/en\/leaps-by-bayer-leads-usd-90m-series-b-round-in-ada-health\/","name":"Leaps by Bayer leads USD 90m Series B round in Ada Health - FYB Financial Yearbook","isPartOf":{"@id":"https:\/\/www.fyb.de\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.fyb.de\/en\/leaps-by-bayer-leads-usd-90m-series-b-round-in-ada-health\/#primaryimage"},"image":{"@id":"https:\/\/www.fyb.de\/en\/leaps-by-bayer-leads-usd-90m-series-b-round-in-ada-health\/#primaryimage"},"thumbnailUrl":"https:\/\/www.fyb.de\/wp-content\/uploads\/2021\/06\/leaps-by-bayer.jpg","datePublished":"2021-06-02T09:15:55+00:00","breadcrumb":{"@id":"https:\/\/www.fyb.de\/en\/leaps-by-bayer-leads-usd-90m-series-b-round-in-ada-health\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.fyb.de\/en\/leaps-by-bayer-leads-usd-90m-series-b-round-in-ada-health\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.fyb.de\/en\/leaps-by-bayer-leads-usd-90m-series-b-round-in-ada-health\/#primaryimage","url":"https:\/\/www.fyb.de\/wp-content\/uploads\/2021\/06\/leaps-by-bayer.jpg","contentUrl":"https:\/\/www.fyb.de\/wp-content\/uploads\/2021\/06\/leaps-by-bayer.jpg","width":1200,"height":848,"caption":"Leaps by Bayer"},{"@type":"BreadcrumbList","@id":"https:\/\/www.fyb.de\/en\/leaps-by-bayer-leads-usd-90m-series-b-round-in-ada-health\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.fyb.de\/en\/"},{"@type":"ListItem","position":2,"name":"Leaps by Bayer leads USD 90m Series B round in Ada Health"}]},{"@type":"WebSite","@id":"https:\/\/www.fyb.de\/en\/#website","url":"https:\/\/www.fyb.de\/en\/","name":"FYB Financial Yearbook","description":"For Your Business","publisher":{"@id":"https:\/\/www.fyb.de\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.fyb.de\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.fyb.de\/en\/#organization","name":"FYB Financial Yearbook","url":"https:\/\/www.fyb.de\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.fyb.de\/en\/#\/schema\/logo\/image\/","url":"https:\/\/www.fyb.de\/wp-content\/uploads\/2020\/06\/logo.svg","contentUrl":"https:\/\/www.fyb.de\/wp-content\/uploads\/2020\/06\/logo.svg","caption":"FYB Financial Yearbook"},"image":{"@id":"https:\/\/www.fyb.de\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/www.fyb.de\/en\/#\/schema\/person\/4308b3086925bc8567ceba3ebd69b4ce","name":"Tatjana Anderer","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.fyb.de\/en\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/11708a5289b743e6290bae8e4109e97efec1cb1ae5c7065f0bfc5c36f28c7757?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/11708a5289b743e6290bae8e4109e97efec1cb1ae5c7065f0bfc5c36f28c7757?s=96&d=mm&r=g","caption":"Tatjana Anderer"},"description":"Gr\u00fcnderin des FYB-Verlag","sameAs":["http:\/\/neu.fyb.de"],"url":"https:\/\/www.fyb.de\/en\/author\/tanderer\/"}]}},"_links":{"self":[{"href":"https:\/\/www.fyb.de\/en\/wp-json\/wp\/v2\/posts\/43505","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.fyb.de\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.fyb.de\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.fyb.de\/en\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.fyb.de\/en\/wp-json\/wp\/v2\/comments?post=43505"}],"version-history":[{"count":0,"href":"https:\/\/www.fyb.de\/en\/wp-json\/wp\/v2\/posts\/43505\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.fyb.de\/en\/wp-json\/wp\/v2\/media\/37497"}],"wp:attachment":[{"href":"https:\/\/www.fyb.de\/en\/wp-json\/wp\/v2\/media?parent=43505"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.fyb.de\/en\/wp-json\/wp\/v2\/categories?post=43505"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.fyb.de\/en\/wp-json\/wp\/v2\/tags?post=43505"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}